Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC
Joe Yeong, Lisda Suteja, Yannick Simoni, Kah Weng Lau, Aaron C. Tan, Hui Hua Li, Sherlly Lim, Jie Hua Loh, Felicia Wee, Sanjna Nilesh Nerurkar, Angela Takano, Eng Huat Tan, Tony Kiat Hon Lim, Evan W. Newell, Daniel S.W. Tan
Topics & Concepts
BlockadeMedicineProgrammed cell death 1Programmed cell deathLigand (biochemistry)CD8ApoptosisCancer researchCytotoxic T cellPD-L1ReceptorCell biologyOncologyImmunologyInternal medicineImmunotherapyAntigenImmune systemBiochemistryBiologyIn vitroCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses